000055 Original Article Antioxidative Vitamine und Glucose-6-Phosphat-Dehydrogenase-Mangel bei ausgereiften Neugeborenen Abdul-Razzak Abdul-Razzak Khalid K. KK PhD

Department of Clinical Pharmacy, Jordan University of Science and Technology, Faculty of Pharmacy, PO Box 3030, Irbid-22110 Jordan, Tel.: 00962 2 7201000 Ext. 23536, Fax: 00962 2 7201075Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan

kkalani@just.edu.jo author Almomany Almomany Enaam M. EM MSc

Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan

enaam_almomany@yahoo.com author Nusier Nusier Mohamad K. MK MD, PhD

Department of Biochemistry and Molecular Biology, Jordan University of Science and Technology, Irbid, Jordan

mick@just.edu.jo author Obediat Obediat Ahmad D. AD

Department of Paediatrics, Princess Rahma Hospital, Irbid, Jordan

dr_ahmadobeidat@yahoo.com author Salim Salim Ahmad M. AM

College of Applied Medical Science, Jordan University of Science and Technology, Irbid, Jordan

biolabstudy@yahoo.com author German Medical Science GMS Publishing House

Düsseldorf

HYPERBILIRUBINEMIA etiology GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY metabolism GLUCOSEPHOSPHATE DEHYDROGENASE genetics ASCORBIC ACID blood VITAMIN E blood HEMOLYSIS HUMANS INFANT, NEWBORN 610 bilirubin vitamin C vitamin E glucose-6-phosphate dehydrogenase deficiency G6PD deficiency Bilirubin Vitamin C Vitamin E Glucose-6-Phosphat-Dehydrogenase-Mangel G6PD-Mangel 20080422 20080814 20080924 engl 1612-3174 6 GMS German Medical Science GMS Ger Med Sci 10 Ziel der Studie: Der Mechanismus, durch den ein Mangel an Glucose-6-Phosphat-Dehydrogenase (G6PD) bei Neugeborenen eine Hyperbilirubinämie erzeugt, ist noch nicht vollständig erforscht. Allerdings schafft der genetische Defekt eines G6PD-Mangels eine Veranlagung der roten Blutzellen zu oxidativem Stress. Das Ziel der vorliegenden Arbeit war es, die Beziehung zwischen den Konzentrationen antioxidativer Vitamine (Vitamin E und C) im Plasma und der Entstehung der Hyperbilirubinämie bei ausgereiften Neugeborenen mit G6PD-Mangel festzustellen. Methoden: 196 Neugeborene von gesunden Müttern wurden in diese Studie eingeschlossen. 12 dieser Neugeborenen hatten einen G6PD-Mangel. Neben den demografischen Daten wurden am 1. Tag nach der Geburt die Konzentrationen von Gesamtbilirubin, Hämoglobin, Hämatokrit sowie Vitamin E und C bestimmt. Ergebnisse: Neugeborene mit einem G6PD-Mangel (n=7), die keine Hyperbilirubinämie entwickelt haben (mittlerer Serum-Bilirubin-Spiegel 70,8±23 µmol/l, median 71,8 µmol/l), und Neugeborene mit einem G6PD-Mangel (n=4), die am 1. Lebenstag eine Hyperbilirubinämie entwickelt haben (mittlerer Serum-Bilirubin-Spiegel 226,7±79 µmol/l, median 233,4 µmol/l), waren in Bezug auf Geburtsgewicht und Schwangerschaftsalter vergleichbar. Die zweite Gruppe wies allerdings niedrigere Konzentrationen von Hämoglobin, Hämatokrit sowie Vitamin C und E auf. Aber keines dieser Messergebnisse zeigte eine signifikante Differenz. Schlussfolgerung: Die Ergebnisse der vorliegenden Studie zeigen, dass Hyperbilirubinämie nicht allein durch Hämolyse als Folge eines unzureichenden Antioxidationssystem bei Neugeborenen mit G6PD-Mangel verursacht wird. Objective: The mechanism by which glucose-6-phosphate dehydrogenase (G6PD) deficiency causes neonatal hyperbilirubinemia is not completely understood. However, the genetic disorder G6PD deficiency predisposes red blood cells to oxidative stress. The aim of this study was to establish the relationship between plasma antioxidant vitamin (E and C) levels and the development of hyperbilirubinemia in full-term neonates with deficient G6PD. Methods: A total of 196 live birth neonates of healthy mothers were included in this study. Twelve of them were deficient in G6PD. In addition to demographic data, serum total bilirubin, hemoglobin, hematocrit, and vitamin E and C levels were measured on the first day after birth. Results: Neonates with G6PD deficiency (n=7) who did not develop hyperbilirubinemia (mean serum bilirubin level of 70.8±23 µmol/l, median 71.8) and neonates with G6PD deficiency (n=4) who developed hyperbilirubinemia (mean serum bilirubin level of 226.7±79 µmol/l, median 233.4) on the first day of life had similar gestational weights and age. The second group, however, had lower hemoglobin and hematocrit as well as plasma vitamin C and E levels. None of these results showed significant difference. Conclusion: The results of the present study indicate that red blood cell hemolysis as a result of inadequate antioxidants system in G6PD-deficient neonates is not the only contributing factor for hyperbilirubinemia. Introduction Glucose-6-phosphate dehydrogenase (G6PD) is the first enzyme in the pentose phosphate pathway in red blood cells . The main physiologic role of this pathway is to generate the reduced nicotinamide adenine dinucleotide phosphate (NADPH) necessary for protection of the cells against oxidative stress . NADPH maintains glutathione in the reduced state when erythrocytes are subjected to an oxidative stress . Low activities of G6PD render red blood cells susceptible to hemolysis under certain conditions such as ingestion of fava beans, certain drugs, and severe infections , . G6PD deficiency is one of the most common human enzyme deficiencies, affecting more than 400 million people worldwide , . Common clinical manifestations of G6PD-deficient subjects are neonatal jaundice and acute hemolytic anemia . Most people with this disorder are male since the inherited deficiency is an X-linked enzymatic defect , . G6PD deficiency is the most significant factor that contributes to severe neonatal hyperbilirubinaemia and kernicterus , . Distribution of the deficiency varies among different populations reflecting geographic and ethnic variations with high prevalence in the Middle East . Antioxidant vitamins (E and C) are considered one of the defense systems against reactive oxygen species . Vitamin E is a potent antioxidant that effectively protects biological membranes against oxidative injury . Supplementation of vitamin E to preterm infants with hyperbilirubinemia results in significant reduction in plasma bilirubin level which is suggested to be caused by a reduction in red cell hemolysis . Previously, we have reported the association between plasma antioxidant vitamins (E and C) and hyperbilirubinemia in full-term neonates . We attributed the significant hyperbilirubinemia to increased oxidative stress due to low levels of antioxidant vitamins and in turn erythrocytes haemolysis. A limited number of studies on the role and status of vitamin E and C in neonate with G6PD deficiency with or without hyperbilirubinemia can be found in literature. Therefore, this study was undertaken to assess the status of plasma vitamin E and C and to establish the relationship between antioxidant vitamin levels and the development of hyperbilirubinemia in full-term neonates with deficient G6PD. Materials and methods Study protocol This study was approved by The Review Committee for Research on Human at Jordan University of Science and Technology (JUST). The population of this study consisted of live birth neonates that consecutively delivered at Princess Rahma Hospital, Irbid-Jordan, for the period from March to July 2004. Both females and males were included in this study. In all cases gender, birth weight and gestational age were recorded. Laboratory analyses All laboratory analyses were conducted on venous blood obtained into heparinized glass tubes from all infants included in this study on the day of birth as stated previously . In brief, plasma total bilirubin level was measured using bilirubin analyzer BA III (Tokyo, Japan). Hemoglobin and hematocrit were measured using automated blood counter (Micros 60 OT, Montpellier, France). For detection of G6PD deficiency, a methemoglobin reduction test was used . Plasma vitamin C level was measured by calorimetric method . Plasma vitamin E level was measured by high performance liquid chromatography (HPLC) . Statistical analysis Data was evaluated by Minitab Statistical Software release 14. Mann-Whitney test was used to compare the significance of median difference between the two groups. P values <0.05 were considered statistically significant. Results During the study period, 196 neonates were studied, out of which 12 (6.1%) were deficient in G6PD enzyme: 11 full-term neonates (10 male and 1 female) and one premature male. Gestational age and birth weight of the two groups showed no significant differences. The hemoglobin and hematocrit were lower in neonates with hyperbilirubinemia than in neonates without hyperbilirubinemia, but the differences were not statistically significant (Table 1 ). Similar results were found for plasma vitamin E and C levels. They were lower in neonates with hyperbilirubinemia than in neonates who did not develop hyperbilirubinemia, but the differences were not statistically significant (Table 2 ). Discussion High bilirubin load due to erythrocyte hemolysis plays an important role in neonatal hyperbilirubinemia. The reasons are higher erythrocyte turnover, shorter life span and diminished capacity of neonatal erythrocytes to deal with oxidative stress as a result of decreased antioxidant defence system particularly in the preterm infants , , , . Erythrocytes are prone to oxidative reactions due to relatively high oxygenation, hemoglobin, and plasma membrane rich in a polyunsaturated fatty acids . The magnitude of hemolysis has been shown to be directly proportional to the amount of free radicals present that can be inhibited by antioxidant substances , . The mechanism by which G6PD deficiency causes neonatal hyperbilirubinemia is not completely understood . Red blood hemolysis may be observed or found to be associated with jaundice in neonates with G6PD deficiency. The genetic disorder G6PD deficiency predisposes red blood cells to oxidative stress and hence, depending on the balance of oxidant species and antioxidants, this may lead to red cell hemolysis and hyperbilirubinemia . Ojo et al. observed that full-term neonates with highest plasma bilirubin levels had lowest plasma vitamin E values, especially in G6PD-deficient erythrocytes. Vitamin E is known to be a cellular antioxidant that prevents membrane damage by inhibiting lipid peroxidation . Vitamin C is a water soluble antioxidant and has also been found to suppress erythrocyte hemolysis induced by water-soluble radical initiator . The synergistic effect between vitamin E and C in inhibition of lipid peroxidation has been reported previously . In our study, neonates of both groups had similar gestational weights and age. Despite these similarities, hemoglobin, hematocrit as well as plasma antioxidant vitamins E and C levels were lower in neonates who developed hyperbilirubinemia. This finding explains the protective action of these vitamins against hemolytic anemia in G6PD-deficient neonates who developed hyperbilirubinemia. This is in agreement with Bizzarro et al. who reported that hemolysis may be observed in neonates with G6PD deficiency and jaundice that exacerbated by oxidative stress . Moreover, our findings indicate that red blood cell hemolysis due to the toxic effects of oxidants and the inadequate antioxidants system are not the only contributing factors for development of hyperbilirubinemia in G6PD-deficient neonates. This corresponds with Jalloh et al. and Kaplan et al. , who found that hemolysis is not the main determinant of neonatal jaundice in G6PD-deficient babies. Hyperbilirubinemia in G6PD-deficient infants is also likely to occur secondary to inability of the liver to adequately conjugate and clear bilirubin as a result of a mutation of uridine diphosphoglucuronate glucuronosyltransferase-1 gene promoter leading to hyperbilirubinemia , . Weng et al. showed that G6PD-deficient neonates were at increased risk for hyperbilirubinemia and that G6PD activity of male newborns that developed hyperbilirubinemia was significantly lower than the neonates without hyperbilirubinemia. This points out the importance of knowing the degree of G6PD activity since this enzyme is responsible for the generation of NADPH, an important factor in the generation of reduced gluthathione, which is an endogenous antioxidant affecting the balance between oxidants and antioxidants. Conclusion In the present study, it was shown that the development of hyperbilirubinemia in G6PD-deficient neonates can not be attributed only to hemolysis of red blood cells as a result of inadequate antioxidants system. Notes Acknowledgements The research is supported by grant from the dean of research council, Jordan University of Science and Technology. Conflict of interest None declared. Kwok CJ Martin AC Au SW Lam VM G6PDdb, an integrated database of glucose-6-phosphate dehydrogenase (G6PD) mutations 2002 Hum Mutat 217-24 Kwok CJ, Martin AC, Au SW, Lam VM. G6PDdb, an integrated database of glucose-6-phosphate dehydrogenase (G6PD) mutations. Hum Mutat. 2002;19(3):217-24. DOI: 10.1002/humu.10036 http://dx.doi.org/10.1002/humu.10036 Jablonska-Skwiecinska E Lewandowska I Plochocka D Topczewski J Zimowski JG Klopocka J Burzynska B Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism 1999 Hum Mutat 477-84 Jablonska-Skwiecinska E, Lewandowska I, Plochocka D, Topczewski J, Zimowski JG, Klopocka J, Burzynska B. Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism. Hum Mutat. 1999;14(6):477-84. DOI: 10.1002/(SICI)1098-1004(199912)14:6<477::AID-HUMU6>3.0.CO;2-X http://dx.doi.org/10.1002/(SICI)1098-1004(199912)14:6<477::AID-HUMU6>3.0.CO;2-X Gaetani GF Rolfo M Arena S Mangerini R Meloni GF Ferraris AM Active Involvement of Catalase During Hemolytic Crises of Favism 1996 Blood 1084-8 Gaetani GF, Rolfo M, Arena S, Mangerini R, Meloni GF, Ferraris AM. Active Involvement of Catalase During Hemolytic Crises of Favism. Blood. 1996;88(3):1084-8. Lim F Vulliamy T Abdalla SH An Ashkenazi Jewish woman presenting with favism 2005 J Clin Pathol 317-9 Lim F, Vulliamy T, Abdalla SH. An Ashkenazi Jewish woman presenting with favism. J Clin Pathol. 2005;58(3):317-9. DOI: 10.1136/jcp.2004.017426 http://dx.doi.org/10.1136/jcp.2004.017426 Mehta A Mason PJ Vulliamy TJ Glucose-6-phosphate dehydrogenase deficiency 2000 Baillieres Best Pract Res Clin Haematol 21-38 Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol. 2000;13(1):21-38. DOI: 10.1053/beha.1999.0055 http://dx.doi.org/10.1053/beha.1999.0055 Turan Y Prevalence of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency in the population of western Turkey 2006 Arch Med Res 880-2 Turan Y. Prevalence of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency in the population of western Turkey. Arch Med Res. 2006;37(7):880-2. DOI: 10.1016/j.arcmed.2006.03.005 http://dx.doi.org/10.1016/j.arcmed.2006.03.005 Laosombat V Sattayasevana B Chotsampancharoen T Wongchanchailert M Glucose-6-Phosphate Dehydrogenase Variants Associated with Favism in Thai Children 2006 Int J Hematol 139-43 Laosombat V, Sattayasevana B, Chotsampancharoen T, Wongchanchailert M. Glucose-6-Phosphate Dehydrogenase Variants Associated with Favism in Thai Children. Int J Hematol. 2006;83(2):139-43. DOI: 10.1532/IJH97.A20513 http://dx.doi.org/10.1532/IJH97.A20513 Usanga EA Ameen R Glucose-6-Phosphate Dehydrogenase Deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon 2000 Hum Hered 158-61 Usanga EA, Ameen R. Glucose-6-Phosphate Dehydrogenase Deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon. Hum Hered. 2000;50(3):158-61. DOI: 10.1159/000022906 http://dx.doi.org/10.1159/000022906 Yeruchimovich M Shapira B Mimouni FB Dollberg S Neonatal Nucleated Red Blood Cells in G6PD Deficiency 2002 Am J Perinatol 215-9 Yeruchimovich M, Shapira B, Mimouni FB, Dollberg S. Neonatal Nucleated Red Blood Cells in G6PD Deficiency. Am J Perinatol. 2002;19(4):215-9. DOI: 10.1055/s-2002-28485 http://dx.doi.org/10.1055/s-2002-28485 Lau HK Li CH Lee AC Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency 2006 Hong Kong Med J 149-51 Lau HK, Li CH, Lee AC. Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency. Hong Kong Med J. 2006;12(2):149-51. Baydas G Karatas F Gursu MF Bozkurt HA Ilhan N Yasar A Canatan H Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status 2002 Arch Med Res 276-80 Baydas G, Karatas F, Gursu MF, Bozkurt HA, Ilhan N, Yasar A, Canatan H. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res. 2002;33(3):276-80. DOI: 10.1016/S0188-4409(02)00356-9 http://dx.doi.org/10.1016/S0188-4409(02)00356-9 Vanderpas J Vertongen F Erythrocyte vitamin E is oxidized at a lower peroxide concentration in neonates than in adults 1985 Blood 1272-7 Vanderpas J, Vertongen F. Erythrocyte vitamin E is oxidized at a lower peroxide concentration in neonates than in adults. Blood. 1985;66(6):1272-7. Gross SJ Vitamin E and neonatal bilirubinemia 1979 Pediatrics 321-3 Gross SJ. Vitamin E and neonatal bilirubinemia. Pediatrics. 1979;64(3):321-3. Abdul-Razzak KK Nusier MK Obediat AD Salim AM Antioxidant vitamins and hyperbilirubinemia in neonates 2007 GMS Ger Med Sci Doc03 Abdul-Razzak KK, Nusier MK, Obediat AD, Salim AM. Antioxidant vitamins and hyperbilirubinemia in neonates. GMS Ger Med Sci. 2007;5:Doc03. Available from: http://www.egms.de/en/gms/2007-5/000039.shtml http://www.egms.de/en/gms/2007-5/000039.shtml Gordon-Smith EC Investigation of the hereditary haemolytic anemia 1984 Practical haematology 152-78 Gordon-Smith EC. Investigation of the hereditary haemolytic anemia. In: Dacie JV, Lewis SM, editors. Practical haematology. Edinburgh: Churchill Livingstone, 1984. p. 152-78. McCormick DB Green HL The vitamins 1999 Tietz text book of clinical chemistry 999-1028 McCormick DB, Green HL. The vitamins. In: Burtis CA, Ashwood ER, editors. Tietz text book of clinical chemistry. Philadelphia: Saunders; 1999. p. 999-1028. Catignani GL Bieri JG Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography 1983 Clin Chem 708-12 Catignani GL, Bieri JG. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 1983;29(4):708-12. Pearson HA Life-span of the fetal red blood cell 1967 J Pediatr 166-71 Pearson HA. Life-span of the fetal red blood cell. J Pediatr. 1967;70(2):166-71. DOI: 10.1016/S0022-3476(67)80410-4 http://dx.doi.org/10.1016/S0022-3476(67)80410-4 Brouillard RP Measurement of red blood cell life-span 1974 JAMA 1304-5 Brouillard RP. Measurement of red blood cell life-span. JAMA. 1974;230(9):1304-5. DOI: 10.1001/jama.230.9.1304 http://dx.doi.org/10.1001/jama.230.9.1304 Connolly AM Volpe JJ Clinical features of bilirubin encephalopathy 1990 Clin Perinatol 371-9 Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol. 1990;17(2):371-9. Kilic M Turgut M Taskin E Cekmen M Aygun AD Nitric oxide levels and antioxidant enzyme activities in jaundices of premature infants 2004 Cell Biochem Funct 339-42 Kilic M, Turgut M, Taskin E, Cekmen M, Aygun AD. Nitric oxide levels and antioxidant enzyme activities in jaundices of premature infants. Cell Biochem Funct. 2004;22(5):339-42. DOI: 10.1002/cbf.1112 http://dx.doi.org/10.1002/cbf.1112 Turgut M Basaran O Cekmen M Karatas F Kurt A Aygün AD Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinemia 2004 J Paediatr Child Health 633-7 Turgut M, Basaran O, Cekmen M, Karatas F, Kurt A, Aygün AD. Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinemia. J Paediatr Child Health. 2004;40(11):633-7. DOI: 10.1111/j.1440-1754.2004.00489.x http://dx.doi.org/10.1111/j.1440-1754.2004.00489.x Kondo H Takahashi M Niki E Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants 1997 FEBS Lett 236-8 Kondo H, Takahashi M, Niki E. Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants. FEBS Lett. 1997;413(2):236-8. DOI: 10.1016/S0014-5793(97)00922-8 http://dx.doi.org/10.1016/S0014-5793(97)00922-8 Niki E Komuro E Takahashi M Urano S Ito E Terao K Oxidative hemolysis of erythrocytes and its inhibition by free radical scavengers 1988 J Biol Chem 19809-14 Niki E, Komuro E, Takahashi M, Urano S, Ito E, Terao K. Oxidative hemolysis of erythrocytes and its inhibition by free radical scavengers. J Biol Chem. 1988;263(36):19809-14. Frank JE Diagnosis and Management of G6PD Deficiency 2005 Am Fam Physician 1277-82 Frank JE. Diagnosis and Management of G6PD Deficiency. Am Fam Physician. 2005;72(7):1277-82 Valaes T Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology 1994 Acta Paediatr Suppl 58-76 Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl. 1994;394:58-76. DOI: 10.1111/j.1651-2227.1994.tb13216.x http://dx.doi.org/10.1111/j.1651-2227.1994.tb13216.x Chan AC Chow CK Chiu D Interaction of antioxidants and their implication in genetic anemia 1999 Proc Soc Exp Biol Med 274-82 Chan AC, Chow CK, Chiu D. Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med. 1999;222(3):274-82. DOI: 10.1046/j.1525-1373.1999.d01-144.x http://dx.doi.org/10.1046/j.1525-1373.1999.d01-144.x Ojo CO Dawodu AH Osifo BO Vitamin E deficiency in the pathogenesis of haemolysis and hyperbilirubinaemia of neonatal jaundice 1986 J Trop Pediatr 251-4 Ojo CO, Dawodu AH, Osifo BO. Vitamin E deficiency in the pathogenesis of haemolysis and hyperbilirubinaemia of neonatal jaundice. J Trop Pediatr. 1986;32(5):251-4. Niki E Yamamoto Y Komuro E Sato K Membrane damage due to lipid oxidation 1991 Am J Clin Nutr 201S-205S Niki E, Yamamoto Y, Komuro E, Sato K. Membrane damage due to lipid oxidation. Am J Clin Nutr. 1991;53(1 Suppl):201S-205S. Strain JJ Mulholland CW Vitamin C and vitamin E - synergistic interaction in vivo? 1992 EXS 419-22 Strain JJ, Mulholland CW. Vitamin C and vitamin E - synergistic interaction in vivo? EXS. 1992;62:419-22. Bizzarro MJ Colson E Ehrenkranz RA Differential diagnosis and management of anemia in the newborn 2004 Pediatr Clin North Am 1087-107, xi Bizzarro MJ, Colson E, Ehrenkranz RA. Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am. 2004;51(4):1087-107, xi. DOI: 10.1016/j.pcl.2004.03.006 http://dx.doi.org/10.1016/j.pcl.2004.03.006 Manco L Gonçalves P Macedo-Ribeiro S Seabra C Melo P Ribeiro ML Two new glucose-6-phosphate dehydrogenase mutations causing chronic hemolysis 2005 Haematologica 1135-6 Manco L, Gonçalves P, Macedo-Ribeiro S, Seabra C, Melo P, Ribeiro ML. Two new glucose-6-phosphate dehydrogenase mutations causing chronic hemolysis. Haematologica. 2005;90(8):1135-6. Jalloh S Van Rostenberghe H Yusoff NM Ghazali S Nik Ismail NZ Matsuo M Wahab NA Nishio H Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies 2005 Pediatr Int 258-61 Jalloh S, Van Rostenberghe H, Yusoff NM, Ghazali S, Nik Ismail NZ, Matsuo M, Wahab NA, Nishio H. Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies. Pediatr Int. 2005;47(3):258-61. DOI: 10.1111/j.1442-200x.2005.02052.x http://dx.doi.org/10.1111/j.1442-200x.2005.02052.x Kaplan M Vreman HJ Hammerman C Leiter C Abramov A Stevenson DK Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates 1996 Br J Haematol 822-7 Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK. Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol. 1996;93(4):822-7. Beutler E Glucose-6-phosphate dehydrogenase deficiency: a historical perspective 2008 Blood 16-24 Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111(1):16-24. DOI: 10.1182/blood-2007-04-077412 http://dx.doi.org/10.1182/blood-2007-04-077412 Weng YH Chou YH Lien RI Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency 2003 Early Hum Dev 129-36 Weng YH, Chou YH, Lien RI. Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency. Early Hum Dev. 2003;71(2):129-36. DOI: 10.1016/S0378-3782(03)00002-1 http://dx.doi.org/10.1016/S0378-3782(03)00002-1 11

Table 1: Demographic data of the neonates studied

22

Table 2: Plasma vitamin E and C levels in the neonates studied

2 0 0 0